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Abstract
Summary We determined if nurses can manage osteoporotic
fractures in a fracture liaison service by asking a rheumatolo-
gist and an internist to assess their clinical decisions. Experts
agreed on more than 94 % of all nurses’ actions for 525 fra-
gility fracture patients, showing that their management is effi-
cient and safe.
Introduction A major care gap exists in the investigation of
bone fragility and initiation of treatment for individuals who
have sustained a fragility fracture. The implementation of a
fracture liaison service (FLS) managed by nurses could be the
key in resolving this problem. The aim of this project was to
obtain agreement between physicians’ and nurses’ clinical
decisions and evaluate if the algorithm of care is efficient
and reliable for the management of a FLS.
Methods Clinical decisions of nurses for 525 subjects in a
fracture liaison service between 2010 and 2013 were assessed
by two independent physicians with expertise in osteoporosis
treatment.
Results Nurses succeeded in identifying all patients at risk and
needed to refer 27 % of patients to an MD. Thereby, they
managed autonomously 73 % of fragility fracture patients.
No needless referrals were made according to assessing phy-
sicians. Agreement between each evaluator and nurses was of
>97 %. Physicians’ decisions were the same in >96 %, and
Gwet AC11 coefficient was of >0.960 (almost perfect level of
agreement). All major comorbidities were adequately
managed.
Conclusions High agreement between nurses’ and physi-
cians’ clinical decisions indicate that the independent manage-
ment by nurses of a fracture liaison service is safe and should
strongly be recommended in the care of patients with a fragil-
ity fracture. This kind of intervention could help resolve the
existing care gap in bone fragility care as well as the societal
economic burden associated with prevention and treatment of
fragility fractures.
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Introduction
Osteoporosis is a chronic disease with fractures as its main
outcome. It has been widely documented that this condition
is treatable and the fractures preventable [1, 2]. Nevertheless,
approximately 30 % of women will be diagnosed with osteo-
porosis and about half of this proportion will receive treatment
following a fragility fracture [3, 4].Moreover, costs associated
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with the treatment of fragility fractures are high worldwide,
ranging from $2.3 billion in Canada (2008), $15 to 20 billion
in the USA, and $37 billion in the European Union (2010)
annually [5–7]. Ageing of the population can only exacerbate
the problem [8].
A lot of effort has been put into the development of man-
agement models for the prevention of subsequent fractures [9,
10]. A high intensity of intervention model of care, such as a
fracture liaison service (FLS), has proven to be one of the best
approaches in reducing the care gap in osteoporosis [11]. A
FLS is characterized by three main interventions (3i): identi-
fication of patients at risk for fracture, investigation for bone
fragility, and initiation of treatment for subsequent fracture
prevention [12, 13]. Our FLS consists in a 4i management,
the fourth Bi^ being integration of follow-up. Indeed, after the
initiation of treatment, a thorough follow-up of patients was
undertaken to ensure persistence, compliance, safety, and pre-
vention of subsequent fractures. A nurse case manager (NCM)
is the dedicated health care professional usually designated to
manage a FLS in collaboration with orthopedic surgeons or
other specialists [14, 15]. Still, the need to assess the manage-
ment of a FLS by nurses remains.
The main goal of the present project was to develop and
implement an algorithm based on the clinical guidelines of
Osteoporosis Canada that could be applied independently by
nurses through an order set. Therefore, the objective of this
study was to determine if nurses can carry out the role of a
NCM in a FLS while ensuring safety of the clinical decisions
regarding identification of patients at risk, investigation for
bone fragility, initiation of treatment, referral to a specialist
when needed, and follow-up.
Methodology
Study design
We conducted a cross-sectional study as part of a larger pro-
spective cohort study that aimed to determine the incidence of
subsequent fractures following initiation of a FLS. Between
2010 and 2013, men and women were identified by NCMs at
the outpatient orthopedic clinic of Hôpital du Sacré-Coeur de
Montréal and Hôpital Jean-Talon. NCMs looked through
medical files to identify patients (1) aged 40 years and older
and (2) with a fracture sustained following a low-energy trau-
ma such as a fall from standing height, from a chair, a bed, and
even from a severe cough or a sneeze [16]. Only patients from
the outpatient orthopedic clinic were identified and recruited.
Exclusion criteria include (1) patients less than 40 years old,
(2) with an open fracture, (3) a fracture from a high energy
trauma, (4) a fracture of the skull/face/little bones under the
wrist or ankle, (5) a pathological fracture, (6) severe kidney
failure, (7) pregnant or breastfeeding, (8) with dementia, or (9)
unable to fill a questionnaire in English or French.
Informed consent was obtained from all participants in-
cluded in the study. This study was approved by the Hôpital
Sacré-Coeur de Montréal and Centre Hospitalier de
l’Université de Montréal ethic research committees.
Data collection
Patients enrolled in the FLS are followed over a 10-year peri-
od with systematic follow-ups (3, 6, 12, 18, 24 months, and
each year). During the baseline evaluation, the NCM collected
the following information: age, sex, body mass index (BMI),
fracture site, number of previous fractures, medications, med-
ical history, and family history. Patients were provided with a
requisition for serum (total blood count, creatinine, thyroid-
stimulating hormone, parathyroid hormone, calcium, protein
electrophoresis, C-reactive protein, alkaline phosphatase, 25-
hydroxy vitamin D, osteocalcin, and C-telopeptide) and bone
mineral density (BMD) testing. Patients were referred to a
bone specialist at baseline for the following reasons: (1) pa-
tients that experienced treatment failure, defined as a fragility
fracture sustained while taking an anti-resorptive agent for at
least a year, (2) aged between 40 and 49 years, or (3) present-
ing a contraindication to treatment. The management algo-
rithm of care followed by NCMs was based on Osteoporosis
Canada guidelines for the prevention of fragility fractures.
This algorithm is summarized in Fig. 1.
Fracture liaison service personnel
This program was managed by a clinical nurse specialist
(CNS) with the help of two clinical nurses. A CNS with a
graduate level of studies and extensive clinical experience
was responsible for the clinical nurses’ training, guidance,
and case discussion with physicians. The training of clinical
nurses for the FLS included a 6-h theoretical presentation
mainly on osteoporosis physiopathology, the management of
fragility fractures, and pharmacological/non-pharmacological
treatment for bone fragility. This was followed by a 2-month
training period with the CNS.
Intervention
Two physicians, a rheumatologist and an internist, with exper-
tise in osteoporosis management and clinical research (JPR
and SNM) evaluated if nurses’ actions in terms of referral
decision and treatment initiation were consistent with the al-
gorithm of care for the 543 subjects (Fig. 2).
Data collected included age, sex, site of fracture, number of
previous fractures, medical history, medication list, blood bio-
chemistry test results, BMD T-scores, BMI, decision of refer-
ral, reason of referral, and initiation of treatment at baseline.
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Blood tests included serum bone turnover biomarkers (CTX-1
and osteocalcin), protein electrophoresis, creatinine, creati-
nine clearance, calcium, 25-hydroxy vitamin D, and parathy-
roid hormone (PTH). All cases were attributed with a number
as their only mean of identification.
Statistical analysis
To ensure a precise and reliable raw agreement between the
nurses and the evaluators, a sample size of subjects to be
reviewedwas calculated based on the purpose of the probability
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to obtain a statistically significant kappa coefficient. Because
we assumed no bias between the two raters, the calculations
based on the Donner and Eliasziw goodness-of-fit formula was
used with a type I probability of error of 0.05, 90 % of power,
an expected proportion of positive ratings of 0.9, a kappa to
detect of 0.8, and a null value of 0.6 [17]. For a two-tailed test,
we needed a sample size of 449 needed «observations» to agree
on or not. Therefore, the whole study population (n=543)
yielded sufficient statistical power.
The primary outcome, the raw agreement between the
nurses and each evaluator, was calculated as the proportion
of nurses’ decisions agreed upon by the evaluators. The same
was done for raw agreement between both evaluators (agree-
ment and disagreement for the same cases). Pearson’s chi-
squared test was used to determine if there was a significant
association between the experts’ answers. A one-proportion z
test with a 95 % confidence interval was used to observe the
difference, if one present, between the obtained total agree-
ment and the hypothesized one, which was of 90 %. No mea-
sure of reliability was calculated for the total agreement be-
cause it included two types of decisions per subject, leaving a
contingency table as not feasible. We considered a p value of
≤0.05 as statistically significant.
Inter-rater reliability was calculated with Cohen’s kappa
coefficient (κ) with 95 % confidence intervals. This statistic
allows to measure raw agreement by adjusting for chance
agreement [18]. The obtained coefficient varies between 1
and −1, where 1 is a perfect agreement, 0 indicates no agree-
ment, and −1 means a perfect disagreement [19]. It was pos-
sible to use this reliability measure with the production of
contingency tables since our variables are dichotomous nom-
inal ones. However, it was necessary to use an alternative to
this measure because of Feinstein and Cicchetti’s «paradox of
kappa» (1990) [20]. It is a possible bias generated by the
agreement distribution in the population, presenting as a low
value of kappa when the agreement is high or the opposite. To
address this problem, a «paradox resistant» option exists,
Gwet’s AC1 coefficient [21]. Here are the formulas of both
coefficients:
κ ¼ p−e Kð Þð Þ= 1−e Kð Þð Þ
AC1 ¼ p−e γð Þð Þ= 1−e γð Þð Þ
where p is the global proportion of agreement and e(K) and
e(γ) represent the agreement probability attributed to chance
[22, 23]. The AC1 coefficient also determines inter-rater
reliability by adjusting agreement for chance but differs in
agreement probability of chance calculation. Instead of es-
timating the probability that an answer is attributed to
chance, the AC1 coefficient estimates the probability of an
observer to agree even if the answer is random. Interpreta-
tion of kappa and AC1 coefficients is based on the Landis
and Koch scale (1977) [19].
Results
Population characteristics
A total of 525 subjects’ data was reviewed by the two physi-
cians. Studied population characteristics according to sex are
shown in Table 1. A significant number of patients had a
diagnosis of osteoporosis, digestive disorders, hypercholester-
olemia, and hypertension. Main fracture sites included the
wrist, ankle, and humerus. Thirty-two percent of patients
had sustained a fragility fracture prior to the index fracture.
Overall, nurses referred almost 27 % of patients to a specialist
mainly for treatment failure and for age 49 years or less, as
pre-specified.
Agreement
Table 2 shows raw agreement between nurses and physicians
as well as the raw agreement between both physicians. Inter-
rater reliability is also presented in this table. More than 97 %
of referral and initiation of treatment decisions by the nurses
were agreed on by either evaluator. Overall, near 95 % of all
nurses’ decisions were agreed on by both evaluators («yes-
yes» answers) (95 % CI [0.925 à 0.964]). There was a signif-
icant positive association between answers of the two physi-
cians for the types of decision (p<0.05). Both evaluators
disagreed on the nurses’ clinical decisions in 5/525 cases
(<1 %). Twenty two out of 525 clinical decisions were
disagreed on by one of the two evaluators, mainly for non-
referral of some patients (under 65 years of age with a major
fracture, on hormonal therapy, low BMD in young patients) or
that were recruited for a stress fracture of the foot.
Our kappa values for inter-rater variability were very low
(<0.370). The paradox of kappa was corrected by calculating
Gwet’s AC1 coefficient where values are higher (>0.960).
These results are consistent with an almost perfect level of
agreement on the scale of Landis and Koch.
Management of major comorbidities
and contraindications/intolerances
When looking at referred patients, three of them were referred
for abnormal screening (high PTH level or a T-score lower
than −5.0). Two patients were referred for very low levels of
bone turnover biomarkers. Fourteen subjects were referred for
contraindication to treatment or intolerance to medication.
Other reasons of referral were major comorbidities.
Regarding non-referred patients, some of them had a med-
ical diagnosis that required particular attention even if a refer-
ral was not necessary (see Fig. 3). Patients with these medical
conditions were not referred to a bone specialist for one of the
following reasons: (1) They were followed by a specialist
before joining the FLS, (2) were prescribed an alternate anti-
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resorptive agent when they were contraindicated (chronic re-
nal failure or gastric problems), or (3) dropped out before a
meeting with our specialist.
Discussion
The main objective of this study was to obtain agreement
between physicians and nurses’ clinical decisions in a FLS.
It was important to determine if nurses can identify a fragility
fracture from a trauma fracture and inform patients about
available care (first i), propose appropriate investigation in
order to rule out causes of secondary osteoporosis (second
i), initiate pharmacological treatment when appropriate (third
i), and follow the patient (fourth i). If so, we also needed to
determine whether a nurse can identify specific health condi-
tions other than the bone fragility, which could require the
intervention of a physician. It was the secondary objective of
this study to assess the algorithm of care used in this program.
Our results show that the overall agreement between the
nurses and both physicians was high (95 %) and significantly
higher than hypothesized (90 %). Individually, the two types
of clinical decisions (referral to specialist and initiation of
treatment) were agreed on by each evaluator up to 97 % and
more. The inter-rater reliability was also a lot higher than
projected, reaching an almost perfect level of agreement ac-
cording to the Landis and Koch scale [19]. Thus, the experts
had a very similar management path and clinical decision
process for patients with fragility fractures. When acknowl-
edging that the physicians practice different specialities (rheu-
matology and internal medicine), the results confirm that the
management of bone fragility is approximately the same be-
tween health professionals. These results suggest that nurses
can efficiently manage a FLS. All patients with major comor-
bidities were adequately managed with a referral to a
Table 1 Study population characteristics according to sex
Women Men
N (%) 452 (86.1) 73 (13.9)
Mean age (years) (±SD) 63.4 (±11.7) 63.2 (±10.5)
Minimum (years) n 39 46
Maximum (years) n 89 89
Fracture sites n(%)
Wrist 184 (40.7) 20 (27.4)
Ankle 71 (15.7) 17 (23.3)
Humerus 62 (13.7) 7 (9.6)
Vertebrae 32 (7.1) 8 (11.0)
Femur 15 (3.3) 8 (11.0)
Hip 13 (2.9) 3 (4.2)
Other 75 (16.6) 10 (13.7)
Patients with previous FF n(%) 150 (33.2) 18 (24.6)
Medical history n(%)
Hypertension 146 (32.3) 39 (53.4)
Osteoporosis 143 (31.6) 5 (6.8)
Gastric disorder 127 (28.1) 9 (12.3)
Dyslipidemia 113 (25.0) 36 (49.3)
Cancer 38 (8.4) 4 (5.5)
Diabetes 32 (7.1) 15 (20.5)
Rheumatoid arthritis 32 (7.1) 0 (0.0)
Osteoarthritis 31 (6.9) 2 (2.7)
Kidney disease 21 (4.6) 7 (9.6)
Myocardial infarction 18 (4.0) 7 (9.6)
Angina 18 (4.0) 3 (4.1)
Stroke 14 (3.1) 7 (9.6)
Inflammatory bowel disease 9 (2.0) 2 (2.7)
Liver disease 8 (1.8) 2 (2.7)
Bowel problems 6 (1.3) 2 (2.7)
Neuromuscular disease 4 (0.9) 1 (1.4)
Patients under BP n(%) 88 (19.5) 3 (4.2)
Patients under calcium and
vitamin D n(%)
138 (30.5) 7 (9.6)
Patients with T-score n(%)a 368 (81.4) 66 (90.4)
Vertebral T-score
[2.5 to −1.0] 94 (25.6) 13 (19.7)
[−1.0 to −2.5] 161 (43.7) 26 (39.4)
[−2.5 and less] 113 (30.7) 27 (40.9)
Femoral T-score
[2.5 to −1.0] 86 (23.4) 15 (22.7)
[−1.0 to −2.5] 229 (62.2) 39 (59.1)
[−2.5 and less] 53 (14.4) 12 (18.2)
Patients with BMI 403 (89.2) 70 (95.9)
Mean (kg/m2) (±SD) 25.6 (±5.2) 27.5 (±5.6)
Minimum (kg/m2) n 13.9 14.8
Maximum (kg/m2) n 49.3 40.9
Patients with CTX-1 306 (67.7) 52 (71.2)
Mean (ng/ml) (±SD) 0.367 (±0.203) 0.357 (±0.168)
CTX-1<300 ng/ml n 128 (41.8) 22 (42.3)
Table 1 (continued)
Women Men
CTX-1>300 ng/ml n 178 (58.2) 30 (57.7)
Referred patients n(%) 130 (28.8) 11 (15.1)
Reasons of referral n(%)
Fracture under BP 66 (50.8) 2 (18.2)
Patient aged <50 years old 40 (30.8) 5 (45.4)
Contraindications/intolerances 14 (10.8) 0 (0.0)
Abnormal screening 2 (1.5) 1 (9.1)
CTX-1/osteocalcin 1 (0.7) 1 (9.1)
Other 7 (5.4) 2 (18.2)
BMD bone mineral density, BP bisphosphonates, CTX-1 C-terminal
telopeptide with type I collagen, FF fragility fracture, SD standard
deviation
a T-score refers to BMD testing
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physician or by insuring that the patient is already followed by
the appropriate health professional. Patients aged between 40
and 49 years were automatically referred to a physician be-
cause they met all the bone fragility criteria except for the
cutoff age of intervention recommended byOsteoporosis Can-
ada, which is 50 years or more. Patients with treatment failure
had to be referred to a physician since alternative treatments
are exceptional medications for which nurses would not have
the authorization to prescribe in an order set.
Since less than 1 % of decisions were not agreed upon by
both evaluators, the management algorithm was found to be
usable in an FLS managed by nurses. These guidelines in-
clude not only the 3i of an FLS (identification, investigation,
initiation of treatment) but also the fourth i: integration.
A high-intensity intervention model is required for the pre-
vention of fragility fractures according to study results
throughout scientific literature [11, 15]. A high-intensity mod-
el of care matches the definition of a fracture liaison service
but omits the monitoring of results and follow-up of patients
(fourth i) [12, 13, 24]. Many studies have demonstrated the
effectiveness of such a service with a NCM as its main con-
tributor [14, 15]. All studies with the aim to determine efficacy
of a FLS listed the interventions done and measured clinical
outcomes as results. All assumed that the NCM was a profes-
sional with the appropriate skills and qualifications to handle
the management of fragility fracture patients. None assessed
the safety and efficacy nor described the necessary training for
such a professional. Furthermore, several studies used a
Table 2 Agreement between nurses and physicians according to the type of clinical decision and inter-rater reliability regarding type of clinical
decision
Agreement between Type of decision N % p Value 95 % CI
Evaluator no. 1 and nurses Referral or not 521 99.2
Initiation of treatment 515 98.1
Evaluator no. 2 and nurses Referral or not 513 97.7
Initiation of treatment 514 97.9
Evaluator no. 1 and no. 2 Referral or not 515 98.1* <0.001
Initiation of treatment 508 96.8* <0.001
Total agreement 498 94.8** <0.001 [0.925, 0.964]**
κ AC1 95 % CI AC1
Referral or not 0.368 0.980 [0.968, 0.992]
Initiation of treatment 0.174 0.966 [0.950, 0.982]
CI confidence interval
*p≤0.05, statistically significant












Fig. 3 Distribution of non-
referred patients to a specialist
regarding their comorbidities
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registered nurse as the NCM [25–28], while the other half
used a specialized nurse [14, 15, 29]. Thus, there was a need
to define which professional should be attributed the NCM
role for a proper and secure intervention.
The difference between registered and specialized nurses
resides in the level of scholar graduation and the number of
years of clinical experience. Depending on the country’s pol-
icies and states/provinces’ regulations, several nursing di-
plomas or roles exist [30]. In general, a registered nurse has
a college degree and a specialized nurse has an advanced
studies degree with a lot of expertise. The best-known roles
of specialized nurses are the nurse practitioner (NP) and the
CNS. They ensure that there is improvement in the manage-
ment of patients, that nurses’ work is optimized, and to the
development of functional, reliable, and effective systems [31,
32]. Moreover, an expert panel determined in 2011 the most
efficient preventive approach in the management of osteopo-
rosis. They indicated that a NCM should be the designated
professional for the management of a fragility fracture system
[33]. A literature review and meta-analysis gathering the re-
sults of physician substitution studies showed that a high level
of skills leads to a better management [34].
In the FLS studied, a CNS works in collaboration with two
clinical nurses, which ensure the first-line intervention with
patients. A pattern of hierarchy was observed; the CNS stood
out with her leadership and management of other nurses’ abil-
ities. As clinical nurses would ensure the recruitment of pa-
tients, data collection, the scheduling of appointments, the
requests for laboratory and radiology tests, referrals to a phy-
sician, and follow-ups with patients, the CNS would guide the
nurses with their clinical decisions and help in recognizing
major comorbidities to be taken care of.
This study’s main strength lies in the high number of cases
or Bobservations^ reviewed by our experts. Also, we were able
to have the participation from two physicians with different
specialities, which was an advantage in demonstrating the
homogeneity of interventions to treat fragility fractures within
health professionals. A possibility of bias exists because of the
physician evaluator no. 1 who was the referral specialist
consulted by six patients included in the study. However, all
patients included for the evaluation by experts were attributed
a number for identification in order to preserve confidentiality.
This reduces the possibility of the evaluator no. 1 recognizing
one of the six patients. It would also have been an option to
exclude these patients of the study, this without affecting its
power. Moreover, this evaluator has reviewed the guidelines
used by nurses in this FLS. However, he was not part of the
group of experts who created the algorithm of care. This study
could not help determine if subsequent fractures could be
prevented by the early intervention of nurses in a 4iFLS.
Losses to follow-up and compliance to treatment are issues
that could not be assessed in the present project. Longitudinal
analyses are yet to come.
This study shows that nurses can efficiently and safely
manage patients with fragility fractures. The implementation
of FLSs (4i), such as the Lucky Bone™ program, with nurses
as case managers with the help of a specialized nurse for
management is feasible and could have a major impact on
health care accessibility. This approach could greatly contrib-
ute on closing the care gap of the underlying osteoporosis in
patients that sustained a fragility fracture.
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